v3.26.1
Unaudited condensed consolidated interim statements of profit or loss - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Statement of profit or loss and other comprehensive income [abstract]    
Product net sales $ 2,813 $ 1,739
Other operating income 41 36
Total operating income 2,854 1,775
Cost of sales (266) (192)
Research and development expenses [1] (929) (642)
Selling, general and administrative expenses (772) (601)
Total operating expenses (1,967) (1,435)
Operating profit 887 340 [2]
Financial income 92 76
Financial expense (2) (2)
Exchange (losses)/gains (19) 76
Profit for the period before taxes 958 489
Income tax expense (119) (74)
Profit for the period 838 415
Profit for the period attributable to:    
Owners of the parent $ 838 $ 415
Weighted average number of shares used for basic profit per share (in shares) 62,185,445 61,034,202
Basic profit per share (in USD per share) $ 13.47 $ 6.80
Weighted average number of shares used for diluted profit per share (in shares) 64,409,488 65,653,007
Diluted profit per share (in USD per share) $ 13.00 $ 6.32
[1] Comparative figures have been presented to be consistent with the one adopted in the current period with respect to the combination of research and
development expenses and loss from investment in a joint venture.
[2] Comparative figures have been presented to be consistent with the one adopted in the current period